NCT01192009

Brief Summary

Leucine supplementation is widely known for promoting strong influence on skeletal muscle remodeling. This study aims to evaluate the effect of leucine supplementation on disuse-induced skeletal muscle atrophy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 31, 2010

Completed
7 months until next milestone

Study Start

First participant enrolled

April 1, 2011

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2013

Completed
Last Updated

February 25, 2013

Status Verified

February 1, 2013

Enrollment Period

1.8 years

First QC Date

August 30, 2010

Last Update Submit

February 22, 2013

Conditions

Keywords

LeucineSkeletal Muscle DisuseAtrophyProteolysis

Outcome Measures

Primary Outcomes (1)

  • Skeletal muscle structure (cross-sectional area)

    2 weeks

Secondary Outcomes (1)

  • Molecular signalling pathways (hypertrophy, atrophy, and inflammation)

    2 weeks

Study Arms (2)

Immobilization and Leucine

EXPERIMENTAL
Dietary Supplement: Leucine

Immobilization and Placebo

PLACEBO COMPARATOR
Dietary Supplement: Placebo

Interventions

LeucineDIETARY_SUPPLEMENT

7.2 g of leucine during 2 weeks

Immobilization and Leucine
PlaceboDIETARY_SUPPLEMENT

7.2 g of alanine during 2 weeks

Immobilization and Placebo

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Clinical diagnosis of anterior cruciate ligament injury
  • Physically active
  • Must be able to swallow tablets
  • Non-smokers
  • Do not use nutritional supplements

You may not qualify if:

  • Post-surgical complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of São Paulo - School of Physical Education and Sports

São Paulo, São Paulo, 05508-030, Brazil

Location

Related Publications (2)

  • Zanchi NE, Nicastro H, Lancha AH Jr. Potential antiproteolytic effects of L-leucine: observations of in vitro and in vivo studies. Nutr Metab (Lond). 2008 Jul 17;5:20. doi: 10.1186/1743-7075-5-20.

    PMID: 18637185BACKGROUND
  • Nicastro H, Artioli GG, Costa Ados S, Solis MY, da Luz CR, Blachier F, Lancha AH Jr. An overview of the therapeutic effects of leucine supplementation on skeletal muscle under atrophic conditions. Amino Acids. 2011 Feb;40(2):287-300. doi: 10.1007/s00726-010-0636-x. Epub 2010 Jun 1.

    PMID: 20514547BACKGROUND

MeSH Terms

Conditions

Muscular Disorders, AtrophicAtrophy

Interventions

Leucine

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Amino Acids, Branched-ChainAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, Essential

Study Officials

  • Humberto Nicastro, PhD Student

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

August 30, 2010

First Posted

August 31, 2010

Study Start

April 1, 2011

Primary Completion

February 1, 2013

Study Completion

February 1, 2013

Last Updated

February 25, 2013

Record last verified: 2013-02

Locations